Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, et al. Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors. Cancer Science. 2021
Ishii M, Hirai I, Tanese K, Fusumae T, Nakamura Y, Fukuda K, Uchi H, Kabashima K, Otsuka A, Yokota K, et al. Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study). Medicine. 2020. 99. 44. e22913
Shiiya C, Ouchi T, Funakoshi T, Amagai M, Takahashi H. Autoimmune and inflammatory diseases occur in cases of drug-induced hypersensitivity syndrome but not in suspected cases. Journal of Dermatology. 2021. 48. 1. e45-e46
Inoue-Masuda Y, Hirai I, Yanagisawa E, Kurihara Y, Funakoshi T, Yamagami J, Amagai M, Kubo A. An adult case of X-linked chronic granulomatous disease with skin ulcer on the nose and internal canthus. Journal of the European Academy of Dermatology and Venereology. 2020. 34. 8. e388-e391
Tahara U, Tanese K, Nakamura Y, Hirai I, Amagai M, Oguro S, Funakoshi T. Successful control of adrenal metastasis with transcatheter arterial chemoembolization in metastatic melanoma patient undergoing treatment with immune checkpoint inhibitor. J Dermatol. 2019. 46. 8. e276-e278
